DEA Meetings & Events
Upcoming Events:
Washington Division- Richmond District Office (RDO)- Diversion Healthcare Summit
Thursday, May 22, 2025 | 9:00 AM – 12:00 PM (EST) | In person and Virtual
The Drug Enforcement Administration- Washington Division will be hosting their 4th Healthcare Summit to present an overview of the federal regulations regarding Controlled Substances (CS) and the responsibilities of DEA Registrants under the Controlled Substances Act (CSA) to ensure the proper handling of CS, and the identification and prevention of diversion activity stemming from various sources.
Audience:
The Richmond District Office (RDO) Healthcare Summit will welcome participants from the City of Richmond, Henrico and Chesterfield Counties, and neighboring areas in Virginia. Audience: DEA Registrants, healthcare professionals, administrative and support personnel, local/state government officials, and students pursuing healthcare-related careers.
Location:
Virginia Commonwealth University Health System- School of Pharmacy Building
Smith Building, Room 103 | 410 N. 12th Street, Richmond, Virginia
(capacity is limited to the first 100 attendees*)
WebEx Webinar Platform- Simultaneous broadcast
Moderator:
Justin G. Wood - Diversion Program Manager, DEA Washington Division
Virtual Registration*: WebEx Webinars (capacity is limited to the first 500 attendees*):
WebEx Virtual Registration - May 22, 2025
In-person Registration* (capacity is limited to the first 100 attendees):
To secure your in-person attendance, kindly fill out the form and send the completed document to: WashingtonDiversionOutreach@dea.gov
In-person Registration Form - May 22, 2025
We will send a confirmation email once the registration has been successfully processed.
*Registration is required. There is no registration fee. This is a LIVE event and not recorded. The program is informational and not for credit.
The contents of the presentations, to include speaker remarks, do not have the force and effect of law and are not meant to bind the public in any way. Is intended only for educational purposes to provide clarity to the public regarding existing resources or requirements under the law or agency policies. The statements contained during the presentations that are not embodied in the law are not binding on DEA.
Any questions regarding this event may be directed to Lillianect Rivas-Mattei, Diversion Program Specialist (Outreach Coordinator) via email to: WashingtonDiversionOutreach@dea.gov
Washington Division - Lunch & Learn Web-series: "Strengthening our Partnerships"
The Washington Division of the Drug Enforcement Administration (DEA) is pleased to continue their Lunch and Learn Web-Series initiative: "Strengthening Our Partnerships". Join us every month for these 30-minute LIVE sessions where DEA speakers and Special Guests present and review information, regulations and procedures related to the proper handling, dispensing, manufacture, distribution and prescribing of Controlled Substances to prevent diversion and help reduce drug poisonings, overdoses and deaths in the District of Columbia, Maryland, and Virginia (DMV).
EMS – DEA Registration Overview
Wednesday, May 28, 2025 | 1:30 – 2:00 PM EST | WebEx Webinar Platform
Moderator/Speaker:
Justin G. Wood - Diversion Program Manager, DEA Washington Division
Speaker:
Edward Logan - Diversion Group Supervisor, DEA Washington Division - Norfolk District Office
Virtual Registration: WebEx Webinars
(capacity is limited to the first 1000 attendees)
Registration to each event is required. There is no registration fee. This is a LIVE event and not recorded. The program is informational only and not for credit.
Any questions regarding this event may be directed to Lillianect Rivas-Mattei, Diversion Program Specialist (Outreach Coordinator) via email to: WashingtonDiversionOutreach@dea.gov
2025 Chemical Industry Virtual Conference
The Diversion Control Division of the Drug Enforcement Administration is pleased to present a Chemical Industry Virtual Conference.
Tuesday, July 22, 2025
1:00 p.m. to 5:00 p.m. EDT
There is no registration fee for this event. Capacity is limited to the first 500 attendees.
The topics covered during this conference include: DEA registration information, import/export requirements, chemical control information, quota update, global and regional precursor chemical trends, and Q&A sessions. The final agenda and other details will be provided prior to the event.
This conference is geared towards DEA Registrants, however, if you have a chemical industry partner who may benefit from attending this conference, please have them contact us at DOC@dea.gov for registration. Additionally, any questions regarding this event may be directed to this email as well.
